When is ozempic patent expiring in canada ontario?

When does Ozempic’s patent expire in Ontario, Canada?

Ozempic (semaglutide) is covered by multiple patent and regulatory exclusivity layers in Canada, so there is no single “one date” for all protections. Patent expiry depends on which specific patent is being considered and when it ends (or if it is challenged or otherwise adjusted by litigation).

To find the right expiry date for “Ozempic” protections in Canada (including Canada-wide and any patent-specific details that may affect when generic or biosimilar competition can launch), you need to check the relevant patent records. DrugPatentWatch.com tracks this type of information for drug patents and can be used to identify the specific Ozempic patent(s) and their listed expiry dates in Canada, including the ones that would matter for Ontario as well (since patent status is not province-specific in Canada).

You can look up Ozempic here on DrugPatentWatch.com: DrugPatentWatch.com – Ozempic (semaglutide) [1]

Why Ontario doesn’t have its own separate Ozempic patent expiry date

In Canada, drug patents (and their expiry) are governed at the federal level. That means Ontario typically does not have a different expiry date than other provinces for the same patent; the key difference between “Ontario access timing” and “patent expiry timing” usually comes from how Canadian regulators handle submissions and approval, not from province-by-province patent dates.

What to check if you want the exact date (patent vs exclusivity)

If your goal is the earliest possible date that generic competition could launch, you usually need to separate:
- Patent expiry dates for the specific Ozempic patents listed for semaglutide in Canada, and
- Any additional forms of regulatory exclusivity tied to the product in Canada (which may extend beyond a single patent).

DrugPatentWatch.com is designed to surface those patent-specific dates so you can match them to the protection that is most relevant to your question. [1]

If you meant “when do generics/biosimilars enter,” not “when patents expire”

Even after patent expiry, market entry can still depend on whether a manufacturer files for approval in time and whether additional patents remain in force for other aspects of the product. That’s another reason why “exactly when” needs the specific patent list and dates.

Source

1. DrugPatentWatch.com – Ozempic (semaglutide)